Virilising ovarian tumors: a single-center experience
Literature on virilising ovarian tumors (VOTs) is limited to case reports and series reporting single pathological type. We have analyzed the clinical, hormonal, radiological, histological, management and outcome data of VOT. This retrospective study was conducted at a tertiary health care center fr...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-11-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0360.xml |
id |
doaj-b43d80c2d71f4557b0ee59b982c00e5c |
---|---|
record_format |
Article |
spelling |
doaj-b43d80c2d71f4557b0ee59b982c00e5c2020-11-25T02:14:53ZengBioscientificaEndocrine Connections2049-36142049-36142018-11-0171213621369https://doi.org/10.1530/EC-18-0360Virilising ovarian tumors: a single-center experienceManjeetkaur Sehemby0Prachi Bansal1Vijaya Sarathi2Ashwini Kolhe3Kanchan Kothari4Swati Jadhav-Ramteke5Anurag R Lila6Tushar Bandgar7Nalini S Shah8Department of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, IndiaDepartment of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, IndiaDepartment of Endocrinology, Narayana Medical College, Nellore, Andhra Pradesh, IndiaDepartment of Pathology, Seth GS Medical college and KEM Hospital, Parel, Mumbai, IndiaDepartment of Pathology, Seth GS Medical college and KEM Hospital, Parel, Mumbai, IndiaDepartment of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, IndiaDepartment of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, IndiaDepartment of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, IndiaDepartment of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai, IndiaLiterature on virilising ovarian tumors (VOTs) is limited to case reports and series reporting single pathological type. We have analyzed the clinical, hormonal, radiological, histological, management and outcome data of VOT. This retrospective study was conducted at a tertiary health care center from Western India. Consecutive patients with VOT presenting to our endocrine center between 2002 and 2017 were included. Our study included 13 patients of VOT. Out of 13 patients, two were postmenopausal. All patients in the reproductive age group had secondary amenorrhea except one who presented with primary amenorrhea. Modified F and G score (mFG) at presentation was 24 ± 4.3 and all patients had severe hirsutism (mFG ≥15). Change in voice (n = 11) and clitoromegaly (n = 7) were the other most common virilising symptoms. Duration of symptoms varied from 4 to 48 months. Median serum total testosterone level at presentation was 5.6 ng/mL with severe hyperandrogenemia (serum testosterone ≥2 ng/mL) but unsuppressed gonadotropins in all patients. Transabdominal ultrasonography (TAS) detected VOT in all except one. Ten patients underwent unilateral salpingo-oophorectomy whereas three patients (peri- or postmenopausal) underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy. Seven patients had Sertoli Leydig cell tumor, three had steroid cell tumor and two had Leydig cell tumor and one had miscellaneous sex cord stromal tumor. All patients had normalization of serum testosterone after tumor excision. In conclusion, VOTs present with severe hyperandrogenism and hyperandrogenemia. Sertoli Leydig cell tumor is the most common histological subtype. Surgery is the treatment of choice with good surgical outcome.https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0360.xmlvirilising ovarian tumortestosteronevirilisationsalpingo-opherectomy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Manjeetkaur Sehemby Prachi Bansal Vijaya Sarathi Ashwini Kolhe Kanchan Kothari Swati Jadhav-Ramteke Anurag R Lila Tushar Bandgar Nalini S Shah |
spellingShingle |
Manjeetkaur Sehemby Prachi Bansal Vijaya Sarathi Ashwini Kolhe Kanchan Kothari Swati Jadhav-Ramteke Anurag R Lila Tushar Bandgar Nalini S Shah Virilising ovarian tumors: a single-center experience Endocrine Connections virilising ovarian tumor testosterone virilisation salpingo-opherectomy |
author_facet |
Manjeetkaur Sehemby Prachi Bansal Vijaya Sarathi Ashwini Kolhe Kanchan Kothari Swati Jadhav-Ramteke Anurag R Lila Tushar Bandgar Nalini S Shah |
author_sort |
Manjeetkaur Sehemby |
title |
Virilising ovarian tumors: a single-center experience |
title_short |
Virilising ovarian tumors: a single-center experience |
title_full |
Virilising ovarian tumors: a single-center experience |
title_fullStr |
Virilising ovarian tumors: a single-center experience |
title_full_unstemmed |
Virilising ovarian tumors: a single-center experience |
title_sort |
virilising ovarian tumors: a single-center experience |
publisher |
Bioscientifica |
series |
Endocrine Connections |
issn |
2049-3614 2049-3614 |
publishDate |
2018-11-01 |
description |
Literature on virilising ovarian tumors (VOTs) is limited to case reports and series reporting single pathological type. We have analyzed the clinical, hormonal, radiological, histological, management and outcome data of VOT. This retrospective study was conducted at a tertiary health care center from Western India. Consecutive patients with VOT presenting to our endocrine center between 2002 and 2017 were included. Our study included 13 patients of VOT. Out of 13 patients, two were postmenopausal. All patients in the reproductive age group had secondary amenorrhea except one who presented with primary amenorrhea. Modified F and G score (mFG) at presentation was 24 ± 4.3 and all patients had severe hirsutism (mFG ≥15). Change in voice (n = 11) and clitoromegaly (n = 7) were the other most common virilising symptoms. Duration of symptoms varied from 4 to 48 months. Median serum total testosterone level at presentation was 5.6 ng/mL with severe hyperandrogenemia (serum testosterone ≥2 ng/mL) but unsuppressed gonadotropins in all patients. Transabdominal ultrasonography (TAS) detected VOT in all except one. Ten patients underwent unilateral salpingo-oophorectomy whereas three patients (peri- or postmenopausal) underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy. Seven patients had Sertoli Leydig cell tumor, three had steroid cell tumor and two had Leydig cell tumor and one had miscellaneous sex cord stromal tumor. All patients had normalization of serum testosterone after tumor excision. In conclusion, VOTs present with severe hyperandrogenism and hyperandrogenemia. Sertoli Leydig cell tumor is the most common histological subtype. Surgery is the treatment of choice with good surgical outcome. |
topic |
virilising ovarian tumor testosterone virilisation salpingo-opherectomy |
url |
https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0360.xml |
work_keys_str_mv |
AT manjeetkaursehemby virilisingovariantumorsasinglecenterexperience AT prachibansal virilisingovariantumorsasinglecenterexperience AT vijayasarathi virilisingovariantumorsasinglecenterexperience AT ashwinikolhe virilisingovariantumorsasinglecenterexperience AT kanchankothari virilisingovariantumorsasinglecenterexperience AT swatijadhavramteke virilisingovariantumorsasinglecenterexperience AT anuragrlila virilisingovariantumorsasinglecenterexperience AT tusharbandgar virilisingovariantumorsasinglecenterexperience AT nalinisshah virilisingovariantumorsasinglecenterexperience |
_version_ |
1724899142374785024 |